1. Home
  2. CRIS vs XOS Comparison

CRIS vs XOS Comparison

Compare CRIS & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • XOS
  • Stock Information
  • Founded
  • CRIS 2000
  • XOS 2016
  • Country
  • CRIS United States
  • XOS United States
  • Employees
  • CRIS N/A
  • XOS N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • XOS Construction/Ag Equipment/Trucks
  • Sector
  • CRIS Health Care
  • XOS Consumer Discretionary
  • Exchange
  • CRIS Nasdaq
  • XOS Nasdaq
  • Market Cap
  • CRIS 22.9M
  • XOS 25.6M
  • IPO Year
  • CRIS 2000
  • XOS N/A
  • Fundamental
  • Price
  • CRIS $1.67
  • XOS $2.64
  • Analyst Decision
  • CRIS Strong Buy
  • XOS Buy
  • Analyst Count
  • CRIS 2
  • XOS 3
  • Target Price
  • CRIS $16.50
  • XOS $9.00
  • AVG Volume (30 Days)
  • CRIS 76.7K
  • XOS 100.3K
  • Earning Date
  • CRIS 11-13-2025
  • XOS 11-12-2025
  • Dividend Yield
  • CRIS N/A
  • XOS N/A
  • EPS Growth
  • CRIS N/A
  • XOS N/A
  • EPS
  • CRIS N/A
  • XOS N/A
  • Revenue
  • CRIS $11,405,000.00
  • XOS $51,536,000.00
  • Revenue This Year
  • CRIS $1.41
  • XOS $4.09
  • Revenue Next Year
  • CRIS $7.46
  • XOS $25.24
  • P/E Ratio
  • CRIS N/A
  • XOS N/A
  • Revenue Growth
  • CRIS 12.24
  • XOS N/A
  • 52 Week Low
  • CRIS $1.02
  • XOS $2.21
  • 52 Week High
  • CRIS $6.44
  • XOS $9.15
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 45.61
  • XOS 45.55
  • Support Level
  • CRIS $1.63
  • XOS $2.28
  • Resistance Level
  • CRIS $1.95
  • XOS $2.39
  • Average True Range (ATR)
  • CRIS 0.15
  • XOS 0.17
  • MACD
  • CRIS 0.00
  • XOS 0.03
  • Stochastic Oscillator
  • CRIS 17.65
  • XOS 52.44

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About XOS Xos Inc.

Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Classes 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.

Share on Social Networks: